IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC includes a print copy delivered by postal mail and on-line access to electronic PDF copies of your subscribed issues.
LEARN MORE
IJPC on Facebook
 
Sign On
  • Home
  • About
    • The Journal
    • Editor-In-Chief
    • Editorial Calendar
    • Submissions
    • Advertising
    • Permissions & Reprints
    • Privacy Policy
  • Subscriptions
    • Subscribe
    • Renew
    • Prices
    • Free Sample
  • Store
    • View Shopping Cart
    • Back Issues
    • Articles
    • Library Archives
    • Compounding Theme Archives
    • Other Products
  • Resources
    • Supplemental Content and Errata
    • Training and Education
    • IJPC-PCAB SOP Matrix
    • USP GAP Analysis
    • Compounders' Network List
    • Patient Information
    • Videos
    • Compounders' Resource Directory
  • Account
  • Contact US

Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product

Author(s):  Allen Loyd V Jr

Issue:  Jul/Aug 2004 - Wound Care
View All Articles in Issue

Abstract:  The purpose of this procedure is to provide a method for documenting the commercial unavailability of a manufactured drug product. A Documentation of the Unavailability of a Commercial Manufactured Drug Product Form, suitable for photocopying and using in the pharmacy, is also provided.

Related Keywords: SOP, for determining and documenting the commercial unavailability of a manufactured drug, Standard operating procedure, for determining and documenting the commercial unavailability of a manufactured drug

Related Categories: SOPs, DISCONTINUED FORMULATIONS

Printer-Friendly Version




Download in electronic PDF format for $35

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Standard Operating Procedure: Determining and Documenting the Commercial Unavailability of a Manufactured Drug Product Allen Loyd V Jr Jul/Aug 2004 292-293 Buy
Determining the Availability of a Commercial Drug Jan/Feb 2003 44-45 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Standard Operating Procedure: SOP Master Book--Maintenance Allen Loyd V Jr Mar/Apr 2005 145 Buy
Zinc Content of Commercial Diluents Widely Use in Drug Admixtures Prepared for Intravenous Infusion Desai Narendra R, Shah Syed M, Koczone Julianna, Vencl-Joncic Maja, Sisto Christopher, Ludwig Stephen A Sep/Oct 2007 426-432 Buy
Standard Operating Procedure: Incubator Temperature Monitoring Allen Loyd V Jr May/Jun 2003 228-229 Buy
Pharmaceutical Compounding or Pharmaceutical Manufacturing? A Regulatory Perspective Timko Robert J, Crooker Philip EM Mar/Apr 2014 101-111 Buy
The Evolution of 21 CFR Parts 210 & 211 for Drug Compounders: An Unspoken Opportunity for Pharmacists Parks Kenneth Chase, Bernard Brian, Cogdill Christopher Blake Sep/Oct 2015 377-380 Buy
Developing Standard Operating Procedures Allen Loyd V Jr May/Jun 2002 224-225 Buy
Improving the Review of Standard Operating Procedures: A Novel Electronic System for Compounding Pharmacies Brensel Robert, Brensel Scott, Ng Amy Nov/Dec 2013 465-475 Buy
Home |  About  |  Contact  |  Advertising |  Privacy Policy                                                            ©2019 IJPC, Inc.